$QBIO QBM-001 is being studied with genetically identified children at high-risk of developing ASD during the toddler years. It is believed that QBM-001 will regulate faulty membrane channels that are known to cause migraines and/or seizures. QBM-001 acts as an allosteric regulator of these faulty channels in the brain to potentially alleviate the condition and allow toddlers to actively develop language and speech and avoid life-long speech and intellectual disability of being non-verbal. QBM-001 also is believed to reduce inflammation in the brain and by so doing may reduce the amount of long-term nerve loss.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.